Fairvalue-Calculator Fairvalue-Calculator
EN DE

Nosa Plugs AB (NOSA) Fair Value & Analysis

Healthcare · SE · Market cap 138M SEK

Pricekr 0.5230
Fair Valuekr 0.4700
Upside-10.1%
Quality95/100
Evidence: Low Range kr 0.3600 – kr 0.5900

Fair value as of: Jun 24, 2026

Analysis

Nosa Plugs AB (NOSA) currently trades at kr 0.5230, while our model-based Fair Value estimate is kr 0.4700 — implying the stock looks roughly 10.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, Europe, North America, Oceania, and internationally. It offers NOSA smell training, a smell training medical device to improve the sense of smell for individuals with parosmia and hyposmia; NOSA odor control, which reduces bad odor; NOSA microbial control that reduces the exposure of viruses and bacteria by inhalation through the nose; NOSA Nozoil original, a moisturizing nasal spray for people suffering from dry nasal mucosa; and NOSA Cerevia, a nasal drug delivery platform for controlled administration of drugs. The company was incorporated in 2014 and is headquartered in Stockholm, Sweden.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Nosa Plugs AB (NOSA) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 0.4700 versus a price of kr 0.5230 — about −10% (overvalued). Model-based estimate, not financial advice.
What is the fair value of NOSA?
Our 21-model fair value for Nosa Plugs AB is kr 0.4700 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 0.5230.
What is the quality score of NOSA?
Nosa Plugs AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.